376 related articles for article (PubMed ID: 33166590)
1. Multi-omics analysis of copy number variations of RNA regulatory genes in soft tissue sarcoma.
Wang X; Han Y; Li J; Hong D; Xue Z; Huang H; Du Z; Hou Y; Li H; Li H; Liao H; Xie X; Ding C
Life Sci; 2021 Jan; 265():118734. PubMed ID: 33166590
[TBL] [Abstract][Full Text] [Related]
2. Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas.
Yang X; Huang WT; He RQ; Ma J; Lin P; Xie ZC; Ma FC; Chen G
J Transl Med; 2019 Aug; 17(1):283. PubMed ID: 31443718
[TBL] [Abstract][Full Text] [Related]
3. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
[TBL] [Abstract][Full Text] [Related]
4. A Prognostic Molecular Signature of N⁶-Methyladenosine Methylation Regulators for Soft-Tissue Sarcoma from The Cancer Genome Atlas Database.
Hou M; Guo X; Chen Y; Cong L; Pan C
Med Sci Monit; 2020 Dec; 26():e928400. PubMed ID: 33370249
[TBL] [Abstract][Full Text] [Related]
5. Integrated genomic and transcriptomic analysis revealed mutation patterns of de-differentiated liposarcoma and leiomyosarcoma.
Liu W; Tong H; Zhang C; Zhuang R; Guo H; Lv C; Yang H; Lin Q; Guo X; Wang Z; Wang Y; Shen F; Wang S; Dai C; Wang G; Liu J; Lu W; Zhang Y; Zhou Y
BMC Cancer; 2020 Oct; 20(1):1035. PubMed ID: 33115433
[TBL] [Abstract][Full Text] [Related]
6. m6A Modification Patterns With Distinct Immunity, Metabolism, and Stemness Characteristics in Soft Tissue Sarcoma.
Huang ZD; Lin LL; Liu ZZ; Hu C; Gu HY; Wei RX
Front Immunol; 2021; 12():765723. PubMed ID: 35003079
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of prognostic markers in sarcomas base on a multi-omics analysis.
Song Y; Yang K; Sun T; Tang R
BMC Med Genomics; 2021 Jan; 14(1):31. PubMed ID: 33509178
[TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis.
Zheng P; Li N; Zhan X
Front Endocrinol (Lausanne); 2022; 13():972341. PubMed ID: 36545327
[TBL] [Abstract][Full Text] [Related]
9. Alterations of cancer-related genes in soft tissue sarcomas: hypermethylation of RASSF1A is frequently detected in leiomyosarcoma and associated with poor prognosis in sarcoma.
Seidel C; Bartel F; Rastetter M; Bluemke K; Wurl P; Taubert H; Dammann R
Int J Cancer; 2005 Apr; 114(3):442-7. PubMed ID: 15551306
[TBL] [Abstract][Full Text] [Related]
10. Cross-Talk of Multiple Types of RNA Modification Regulators Uncovers the Tumor Microenvironment and Immune Infiltrates in Soft Tissue Sarcoma.
Qi L; Zhang W; Ren X; Xu R; Yang Z; Chen R; Tu C; Li Z
Front Immunol; 2022; 13():921223. PubMed ID: 35860263
[TBL] [Abstract][Full Text] [Related]
11. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of PLAGL1-specific CpG site methylation in soft-tissue sarcomas.
Peille AL; Brouste V; Kauffmann A; Lagarde P; Le Morvan V; Coindre JM; Chibon F; Bresson-Bepoldin L
PLoS One; 2013; 8(11):e80741. PubMed ID: 24260468
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.
;
Cell; 2017 Nov; 171(4):950-965.e28. PubMed ID: 29100075
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
[TBL] [Abstract][Full Text] [Related]
15. Gene Characteristics and Prognostic Values of m
Li N; Chen X; Liu Y; Zhou T; Li W
J Healthc Eng; 2021; 2021():2257066. PubMed ID: 34367534
[TBL] [Abstract][Full Text] [Related]
16. Copy number variation analysis of m
Wang X; Yu J; Chen J; Hou Y; Du Z; Huang H; Tang S; Han Y; Ding C; Xue Z
Cancer Med; 2021 Nov; 10(21):7804-7815. PubMed ID: 34668652
[TBL] [Abstract][Full Text] [Related]
17. The construction and analysis of tumor-infiltrating immune cell and ceRNA networks in recurrent soft tissue sarcoma.
Huang R; Meng T; Chen R; Yan P; Zhang J; Hu P; Zhu X; Yin H; Song D; Huang Z
Aging (Albany NY); 2019 Nov; 11(22):10116-10143. PubMed ID: 31739284
[TBL] [Abstract][Full Text] [Related]
18. m6A-related metabolism molecular classification with distinct prognosis and immunotherapy response in soft tissue sarcoma.
Huang ZD; Fu YC; Liu SY; Mao YJ; Zhang Y; Hu C; Wei RX
Front Immunol; 2022; 13():895465. PubMed ID: 35967408
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of ferroptosis in soft tissue sarcoma constructs a prognostic and immunotherapeutic signature through experimental and bioinformatics analyses.
Yang ZQ; Guo LY; Xiao KW; Zhang C; Wu MH; Yan FF; Cai L
Aging (Albany NY); 2023 Oct; 15(20):11412-11447. PubMed ID: 37874682
[TBL] [Abstract][Full Text] [Related]
20. Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation.
Zheng M; Hu Y; Gou R; Nie X; Li X; Liu J; Lin B
Biomed Pharmacother; 2020 Apr; 124():109810. PubMed ID: 32000042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
